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Introduction
Extracorporeal life support (ECLS) seems an efficient
therapy for acute, potentially reversible cardiac or
respiratory failure, when conventional therapy has been
inadequate, or as bridge to transplant, but there is no
evidence for cost-effectiveness. Our aim was to conduct
an exploration of the hospital costs of ECLS therapy.
Objectives
Single-center retrospective exploratory cohort cost
study. The study is performed from a hospital perspec-
tive with a time horizon of patients’ complete hospital
admission in which they received ECLS.
Methods
All 67 consecutive adult patients who were admitted to
the ICU of the University Medical Center Groningen
(the Netherlands) in the period 2010 to 2013 and
received ECLS treatment were included. The bottom-up
micro costing method was used. Medical costs were
estimated by multiplying every registered healthcare
consumption with unit prices. Unit prices were largely
based on Dutch reference prices. For each patient the
personnel costs and material costs were assessed in
detail. The costs of ECLS were differentiated in costs of
procedures and costs of daily surcharge of therapy. Pro-
cedure related costs were subdivided in costs of devices
and disposables, costs of additional human resources
and surgery hours.
In order to estimate costs of ECLS therapy based on
indication all patients were categorized into six different
subgroups: respiratory - bridge to recovery, respiratory -
bridge to transplant, cardiac - bridge to recovery, cardiac -
bridge to transplant, cardiac - post-cardiotomy, and ECPR.
Results
The mean age was 46 years, female sex 66%, APACHE
II score 24, ECLS duration 135 ± 163 hours, ICU length
of stay 18 ± 22, hospital length of stay 38 ± 45, and in
hospital mortality 68%. The mean total hospital costs
were €106.263 (€83.841 - €126.266) per patient. On
average, 52% of the total costs arose from hospital nur-
sing days and 11% of direct procedure related ECLS
costs. Surgery and diagnostics represented a vast
amount of the remaining costs.
Conclusions
This large and detailed economic evaluation of hospital
costs of ECLS therapy in the Netherlands showed that
mean total hospital cost of ECLS treatment are
€106.263 per patient. The majority of the costs are com-
posed of hospital nursing days.
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All patients 106.263 2,796
respiratory - bridge to
recovery
110,553 2,571
respiratory - bridge to
transplant
153,345 2,513
cardiac - bridge to
recovery
69,803 5,369
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